• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, April 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Sanford Burnham Prebys elects Professor Nicholas Cosford to its Board of Trustees

Bioengineer by Bioengineer
March 9, 2023
in Chemistry
Reading Time: 2 mins read
0
Nicholas Cosford, Ph.D.
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

LA JOLLA, CALIF. – Mar, 09, 2023 – Sanford Burnham Prebys today announced that Professor Nicholas Cosford, Ph.D., will join the Institute’s Board of Trustees. 

Nicholas Cosford, Ph.D.

Credit: Sanford Burnham Prebys

LA JOLLA, CALIF. – Mar, 09, 2023 – Sanford Burnham Prebys today announced that Professor Nicholas Cosford, Ph.D., will join the Institute’s Board of Trustees. 

“Scientists are the lifeblood of our research institute, and the interaction between our scientists and our Board of Trustees needs to be strengthened. A logical step in this process is to have representation from faculty on the Board so their perspective is included in key decisions,” says President and CEO David Brenner, M.D. “With his extensive experience in academia and industry, as well as his tenure here at the Institute, I am confident that Nick is the ideal person to fill this role.”

Prior to joining the Institute in 2005, Cosford worked as a medicinal chemist in the biotechnology and pharmaceutical industries. His research has resulted in more than 100 peer-reviewed scientific publications, more than 100 issued patents, and more than 50 additional pending patent applications. Currently, a first-in-class drug discovered in Cosford’s lab is in a Phase 1 clinical study for the treatment of nicotine addiction. Cosford and his team are also working on applying their approach to other substance use disorders.

“I am honored to have been appointed to the Board,” says Cosford. “Sanford Burnham Prebys is a world-class academic biomedical research institute. It has been gratifying and exciting to be a part of the Institute for a significant portion of my career. I’m looking forward to working with the Board to help guide the Institute through its next phase of growth that will support research leading to the discovery and development of breakthrough medicines for unmet medical needs.”

Cosford received his B.Sc. in chemistry and his Ph.D. in organic chemistry from the University of Bath in England, and subsequently pursued postdoctoral studies at Emory University in Atlanta, Georgia. 

###

About Sanford Burnham Prebys

Sanford Burnham Prebys is an independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 45 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.



Share12Tweet8Share2ShareShareShare2

Related Posts

Local Universe Expansion Rate More Precise Than Ever — Yet Still Mysteriously Inconsistent

Local Universe Expansion Rate More Precise Than Ever — Yet Still Mysteriously Inconsistent

April 11, 2026
Breakthrough in Mainz: New Dual-Frequency Paul Trap Achieves Milestone Toward Antihydrogen Creation

Breakthrough in Mainz: New Dual-Frequency Paul Trap Achieves Milestone Toward Antihydrogen Creation

April 10, 2026

Ultra-Low Efficiency Roll-Off and Over 20% Efficiency Achieved in High Color Purity Blue Perovskite QLEDs

April 10, 2026

Bumblebee Bacterium Enables Vitamin B2 Production in Soya Drinks

April 10, 2026

POPULAR NEWS

  • Boosting Breast Cancer Risk Prediction with Genetics

    47 shares
    Share 19 Tweet 12
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1012 shares
    Share 400 Tweet 250
  • Revolutionary Theory Transforms Quantum Perspective on the Big Bang

    41 shares
    Share 16 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Digital Communication Boosts Elderly Care Use in Norway

High-Capacity Optical Relay Boosts Submarine Seven-Core Cable

Short-Term PM2.5 Exposure Links to Mortality in Iran

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.